Category:

Policy

Can’t be mute spectator in national crisis, don’t intend to supplant HC cases on COVID-19: SC

There is a need for top court’s intervention on certain national issues as there might be matters related to coordination between states, it said.

“We are playing complementary role, if High Courts have any difficulty in dealing with issues due to territorial limitations, we will help,” said the bench, also comprising Justices L Nageswara Rao and S Ravindra Bhat.

read more

Bankers call for more bang to Britain’s big finance fightback

Much is at stake given that Britain’s financial services sector employs 1.1 million people and raises about 75.5 billion pounds a year in tax, a figure which consultants PwC expect to ease in 2021 due to the City of London being effectively cut off from the EU, hitherto its biggest export market.

But many rule changes will need legislation, meaning they may not come into effect until 2022 or beyond.

read more

Govt issues updated clinical guidance for management of Covid-19 patients

Under emergency use authorisation (EUA), remdesivir may be considered for only those patients with moderate to severe diseases (requiring supplemental oxygen) within 10 days of onset of symptoms.

It is not recommended for those with severe renal impairment or hepatic dysfunction, the guidelines stated.

“Not to be used in patients who are not on oxygen support or in home settings,” the ministry underlined.

read more

Covid vaccine-makers largely protected on side effects

While some governments will pay compensation due to sufferers, others assume it is the responsibility of the companies even after drug agencies back the vaccines.
In the US, the Public Readiness and Emergency Preparedness Act authorises the health secretary “to limit legal liability for losses relating to the administration of medical countermeasures such as diagnostics, treatments, and vaccines”.

read more

China launches first class-action lawsuit in war against corporate fraud

China introduced the class-action mechanism to capital markets last year as part of efforts to crack down on corporate malfeasance and bolster investor confidence.

Although corporate fraud is not uncommon in China, retail investors have historically had little chance to make their voices heard. Small investors often likened legal action to ants fighting elephants.

read more